Retrospective Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease
NCT ID: NCT03584321
Last Updated: 2018-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1600 participants
OBSERVATIONAL
2017-09-13
2018-07-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Subclinical Atherosclerosis in Asymptomatic Individuals
NCT00862056
Prospective Registry of the Current Status of Care for Patients With Coronary Artery Disease
NCT05337319
Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI
NCT05880355
Risk Factor Analysis for Coronary Atherosclerosis Measured by MDCT
NCT01589224
Evaluation of Diagnostic Accuracy of MCG(Magnetocardiography) Scan in Suspected Coronary Artery Disease
NCT05825911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with Coronary Artery Disease
Participants with suspected or confirmed coronary artery disease who underwent coronary angiography during 01 Jan 2013 and 31 Dec 2015 will be observed in the study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Underwent CAG between 01 Jan 2013 and 31 Dec 2015
Exclusion Criteria
* Participant with history of myocardial infarction
* Participant with history of cardiac transplant or valve surgery
* Presenting with Acute myocardial infarction for coronary angiography
* CAG showed myocardial bridge and coronary stenosis greater than or equal to 50 percent during systole period
* Incomplete or missing data in CAG report
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Serono Co., Ltd., China
INDUSTRY
Merck KGaA, Darmstadt, Germany
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Responsible
Role: STUDY_DIRECTOR
Merck Serono Co., Ltd, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Please Contact the Merck KGaA Communication Center
Darmstadt, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS200101_0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.